MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD)

Clinical trials for MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD) explained in plain language.

Never miss a new study

Get alerted when new MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD) trials appear

Sign up with your email to follow new studies for MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hope for mitochondrial disease patients: new drug targets debilitating fatigue

Symptom relief Recruiting now

This study is testing whether a medicine called sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific type of mitochondrial disease. About 220 participants will take either the real medicine or a placebo pill twice…

Matched conditions: MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD)

Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief

Last updated Mar 30, 2026 14:28 UTC

MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD)

Get alerted when new MATERNALLY INHERITED DIABETES AND DEAFNESS (MIDD) trials appear

Hope for mitochondrial disease patients: new drug targets debilitating fatigue